Oracle Co. (NYSE:ORCL) Receives $145.83 Average PT from Analysts

Shares of Oracle Co. (NYSE:ORCL) have earned an average recommendation of “Moderate Buy” from the thirty ratings firms that are presently covering the firm, MarketBeat Ratings reports. Thirteen investment analysts have rated the stock with a hold recommendation and seventeen have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $145.83.

A number of analysts have recently issued reports on ORCL shares. Morgan Stanley reiterated an “equal weight” rating and set a $125.00 target price on shares of Oracle in a report on Tuesday, June 25th. TD Cowen raised their price objective on Oracle from $145.00 to $165.00 and gave the company a “buy” rating in a research report on Wednesday, June 12th. Oppenheimer initiated coverage on Oracle in a research report on Thursday, April 18th. They issued a “market perform” rating for the company. Argus increased their target price on Oracle from $145.00 to $159.00 and gave the company a “buy” rating in a research note on Tuesday, June 18th. Finally, Mizuho boosted their price target on Oracle from $160.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, June 17th.

Oracle Price Performance

Oracle stock opened at $142.78 on Friday. The company has a debt-to-equity ratio of 8.25, a quick ratio of 0.72 and a current ratio of 0.71. The company has a market cap of $393.48 billion, a price-to-earnings ratio of 38.49, a PEG ratio of 2.63 and a beta of 1.02. Oracle has a 1 year low of $99.26 and a 1 year high of $145.79. The firm has a 50 day moving average price of $130.30 and a 200 day moving average price of $120.43.

Oracle (NYSE:ORCL) last released its quarterly earnings data on Tuesday, June 11th. The enterprise software provider reported $1.63 EPS for the quarter, missing analysts’ consensus estimates of $1.65 by ($0.02). Oracle had a return on equity of 223.01% and a net margin of 19.76%. The firm had revenue of $14.29 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same quarter in the previous year, the company earned $1.35 earnings per share. The company’s quarterly revenue was up 3.3% on a year-over-year basis. Sell-side analysts predict that Oracle will post 5.01 earnings per share for the current year.

Oracle Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 25th. Stockholders of record on Thursday, July 11th will be given a $0.40 dividend. The ex-dividend date is Thursday, July 11th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.12%. Oracle’s payout ratio is currently 43.13%.

Insider Activity at Oracle

In other Oracle news, Director George H. Conrades sold 20,000 shares of the firm’s stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $116.00, for a total value of $2,320,000.00. Following the transaction, the director now owns 17,836 shares of the company’s stock, valued at $2,068,976. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Edward Screven sold 426,861 shares of the company’s stock in a transaction dated Wednesday, July 10th. The shares were sold at an average price of $141.91, for a total transaction of $60,575,844.51. Following the completion of the transaction, the insider now owns 2,626,764 shares in the company, valued at $372,764,079.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director George H. Conrades sold 20,000 shares of Oracle stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $116.00, for a total transaction of $2,320,000.00. Following the completion of the sale, the director now owns 17,836 shares in the company, valued at $2,068,976. The disclosure for this sale can be found here. Insiders sold a total of 812,500 shares of company stock valued at $113,578,574 in the last quarter. Insiders own 42.80% of the company’s stock.

Institutional Investors Weigh In On Oracle

Several large investors have recently made changes to their positions in ORCL. Abich Financial Wealth Management LLC boosted its position in Oracle by 18.0% during the 1st quarter. Abich Financial Wealth Management LLC now owns 530 shares of the enterprise software provider’s stock worth $67,000 after acquiring an additional 81 shares during the period. Invst LLC grew its position in Oracle by 2.7% in the 4th quarter. Invst LLC now owns 3,299 shares of the enterprise software provider’s stock valued at $380,000 after buying an additional 86 shares in the last quarter. Nemes Rush Group LLC increased its stake in Oracle by 1.2% during the 4th quarter. Nemes Rush Group LLC now owns 7,334 shares of the enterprise software provider’s stock valued at $773,000 after buying an additional 86 shares during the period. CJM Wealth Advisers Ltd. raised its position in shares of Oracle by 4.0% during the 2nd quarter. CJM Wealth Advisers Ltd. now owns 2,306 shares of the enterprise software provider’s stock worth $330,000 after buying an additional 88 shares in the last quarter. Finally, Avidian Wealth Solutions LLC lifted its stake in shares of Oracle by 1.1% in the 4th quarter. Avidian Wealth Solutions LLC now owns 8,516 shares of the enterprise software provider’s stock worth $898,000 after acquiring an additional 90 shares during the period. Institutional investors and hedge funds own 42.44% of the company’s stock.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.